WBA · Insider Trading
Walgreens Boots Alliance, Inc
Every open-market purchase and sale reported by WBA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-28 | Timothy C Wentworth | Chief Executive Officer | D | −1,332,014 | — |
| 2025-08-28 | Lanesha Minnix | EVP, Global CLO & Corp. Sec. | D | −348,093 | — |
| 2025-08-28 | Beth Amber L. Fabbri | SVP Chief Corp Affairs Officer | D | −124,670 | — |
| 2025-08-28 | Todd Heckman | SVP, Global Controller and CAO | D | −93,037 | — |
| 2025-08-28 | Elizabeth Burger | EVP, Global Chief HR Officer | D | −303,875 | — |
| 2025-08-28 | Tracey D Brown | EVP, Pres., Walgreens Retail | D | −348,051 | — |
| 2025-08-28 | Richard P. Gates | SVP, Chief Pharmacy Officer | D | −145,444 | — |
| 2025-08-28 | Ornella Barra | Chief Operating Officer, Int'l | D | −2,687,057 | −$30.77M |
| 2025-08-28 | Mary Langowksi | EVP, President U.S. Healthcare | D | −494,295 | — |
| 2025-08-28 | Stefano Pessina | Executive Chairman of Board | D | −146,938,623 | −$1.68B |
| 2025-08-28 | Manmohan Mahajan | EVP and Global CFO | D | −414,273 | — |
| 2025-08-15 | Nancy M Schlichting | Director | A | +16,820 | — |
| 2025-08-15 | Robert Luther Huffines | Director | A | +16,820 deriv. | — |
| 2025-08-15 | Bryan C Hanson | Director | A | +16,820 | — |
| 2025-08-15 | Valerie B Jarrett | Director | A | +16,820 deriv. | — |
| 2025-08-15 | Ginger L Graham | Director | A | +16,820 deriv. | — |
| 2025-08-15 | William H Shrank | Director | A | +16,820 deriv. | — |
| 2025-08-15 | Inderpal S Bhandari | Director | A | +16,820 deriv. | — |
| 2025-08-15 | Thomas E Polen Jr | Director | A | +11,774 | — |
| 2025-08-15 | Janice M. Babiak | Director | A | +16,820 deriv. | — |
| 2025-08-15 | John Anthony Lederer | Director | A | +16,820 deriv. | — |
| 2025-07-11 | Robert Luther Huffines | Director | A | +2,158 deriv. | — |
| 2025-07-11 | Valerie B Jarrett | Director | A | +2,590 deriv. | — |
| 2025-07-11 | John Anthony Lederer | Director | A | +2,590 deriv. | — |
| 2025-06-03 | Elizabeth Burger | EVP, Global Chief HR Officer | F | −16,495 | −$185.32K |
| 2025-06-03 | Lanesha Minnix | EVP, Global CLO & Corp. Sec. | F | −19,135 | −$214.98K |
| 2025-06-03 | Mary Langowksi | EVP, President U.S. Healthcare | F | −40,304 | −$452.82K |
| 2025-04-29 | Stefano Pessina | Executive Chairman of Board | MIXED | — | — |
| 2025-04-18 | John Anthony Lederer | Director | A | +2,777 deriv. | — |
| 2025-04-18 | Robert Luther Huffines | Director | A | +2,314 deriv. | — |
| 2025-04-18 | Valerie B Jarrett | Director | A | +2,777 deriv. | — |
| 2025-03-04 | Todd Heckman | SVP, Global Controller and CAO | F | −1,545 | −$17.35K |
| 2025-03-04 | Beth Amber L. Fabbri | Chief Corp. Affairs Officer | F | −1,741 | −$19.55K |
| 2025-03-04 | Tracey D Brown | EVP, Pres., Walgreens Retail | F | −1,354 | −$15.21K |
| 2025-03-04 | Manmohan Mahajan | EVP and Global CFO | F | −10,706 | −$120.23K |
| 2025-02-03 | John Anthony Lederer | Director | A | +2,617 deriv. | — |
| 2025-02-03 | Robert Luther Huffines | Director | A | +2,181 deriv. | — |
| 2025-02-03 | Valerie B Jarrett | Director | A | +2,326 deriv. | — |
| 2024-11-05 | William H Shrank | Director | A | +3,523 | — |
| 2024-11-05 | Nancy M Schlichting | Director | A | +21,141 | — |
| 2024-11-05 | Robert Luther Huffines | Director | A | +15,856 deriv. | — |
| 2024-11-05 | Bryan C Hanson | Director | A | +21,141 | — |
| 2024-11-05 | Thomas E Polen Jr | Director | A | +14,799 | — |
| 2024-11-05 | Elizabeth Burger | EVP, Global Chief HR Officer | A | +147,059 | — |
| 2024-11-05 | Timothy C Wentworth | Chief Executive Officer | MIXED | +683,890 | −$739.22K |
| 2024-11-05 | Inderpal S Bhandari | Director | A | +21,141 deriv. | — |
| 2024-11-05 | Ginger L Graham | Director | A | +21,141 deriv. | — |
| 2024-11-05 | Tracey D Brown | EVP, Pres., Walgreens Retail | MIXED | +151,527 | −$152.50K |
| 2024-11-05 | Valerie B Jarrett | Director | A | +21,141 deriv. | — |
| 2024-11-05 | Todd Heckman | SVP, Global Controller and CAO | MIXED | +48,366 | −$23.04K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Neal J. Sample | EVP, Chief Information Officer | 401,878 | $4.81M |
| John Anthony Lederer | Director | 50,000 | $599.00K |
| Bryan C Hanson | Director | 47,655 | $570.91K |
| Nancy M Schlichting | Director | 37,961 | $454.77K |
| Thomas E Polen Jr | Director | 28,269 | $338.66K |
| Valerie B Jarrett | Director | 4,456 | $53.38K |
| William H Shrank | Director | 3,523 | $42.21K |
| Inderpal S Bhandari | Director | 3,000 | $35.94K |
| Ginger L Graham | Director | 2,150 | $25.76K |
| Janice M. Babiak | Director | 1,200 | $14.38K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the WBA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.